Skip to content

Alpha Cognition ACOG Accumulated Depreciation

Accumulated Depreciation at other companies

Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
$44.13M+1.1%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$469.01M+20.7%
Biogen logo
BiogenBIIB
AbbVie logo
AbbVieABBV

Other financials

Income statement

See full
Revenue$3.5M+20.7%
Gross profit$3.3M+12.7%
Operating income-$8.1M-138%
Net income-$6.5M-276%
EPS (diluted)-$0.32-191%

Balance sheet

See full
Cash & equivalents$54.3M+100,638%
Total equity$57.5M+49.2%
Total assets$69.2M+42.5%

Cash flow

See full
Operating cash flow-$11.8M-477%
CapEx$1.3K-97.9%
Free cash flow-$11.8M-460%

Valuation

See full
Market cap$157.21M+6.6%
P/S14.5×

Profitability

See full
Gross margin89.3%
Operating margin-250.1%
Net margin-232.2%
FCF margin-280.5%

Returns & leverage

See full
Return on equity-52.4%-5.3pp
Current ratio12.6×-4.5×

Where this comes from

Reported directly by Alpha Cognition in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.

The official record: Alpha Cognition’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alpha Cognition's accumulated depreciation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alpha Cognition's accumulated depreciation?
Alpha Cognition (ACOG) reported accumulated depreciation of $799.6K in Q1 2026.
How has Alpha Cognition's accumulated depreciation changed year-over-year?
Alpha Cognition's accumulated depreciation increased by 5657.1% year-over-year, from $13.89K to $799.6K.
What is the long-term trend for Alpha Cognition's accumulated depreciation?
Over 2 years (2023 to 2025), Alpha Cognition's accumulated depreciation has grown at a 763.6% compound annual growth rate (CAGR), from $10.65K to $794.21K.
What does accumulated depreciation mean?
Total accumulated depreciation on property, plant, and equipment since acquisition — represents the consumed portion of asset useful lives.